Key result
Seropositivity against EV71 and CA16 was lowest in children aged 6-11 months and gradually increased with age, remaining below 50% in children younger than 3 years.
Cross-Sectional (n=579)
Answers are grounded in this paper and cite their sources.
Children under 3 years of age in Thailand have low seroprevalence of neutralizing antibodies to EV71 and CA16, making them highly vulnerable to hand, foot, and mouth disease.
BACKGROUND: Hand, foot and mouth disease (HFMD) is endemic among population of young children in Thailand. The disease is mostly caused by enterovirus 71 (EV71) and coxsackievirus A16 (CA16). METHODS: This study conducted serosurveillance for neutralizing (NT) antibodies to EV71 subgenotypes B5 and C4a, and to CA16 subgenotypes B1a and B1b, in 579 subjects of various ages using a microneutralization assay in human rhabdomyosarcoma (RD) cells. These test viruses were the major circulating subgenotypes associated with HFMD in Thailand during the study period. RESULTS: We found that the levels of seropositivity against all 4 study viruses were lowest in the age group of 6-11 months, i.e., 5.5% had antibody to both EV71 subgenotypes, while 14.5% and 16.4% had antibody to CA16 subgenotypes B1a and B1b, respectively. The percentages of subjects with antibodies to these 4 viruses gradually increased with age, but were still less than 50% in children younger than 3 years. These laboratory data were consistent with the epidemiological data collected by the Ministry of Public Health which showed repeatedly that the highest number of HFMD cases was in children aged 1 year. Analyses of amino acid sequences of the test viruses showed 97% identity between the two subgenotypes of EV71, and 99% between the two subgenotypes of CA16. Nevertheless, the levels of seropositivity and antibody titer against the two subgenotypes of EV71 and of CA16 were not significantly different. CONCLUSIONS: This study clearly demonstrated NT antibody activity across EV71-B5 and EV71-C4a subgenotypes, and also across CA16-B1a and CA16-B1b subgenotypes. Moreover, there were no significant differences by gender in the seropositive rates and antibody levels to any of the 4 virus subgenotypes.
No takes yet. Share an insight, caveat, or question.
Lerdsamran et al. (2018) conducted a cross-sectional in Hand, foot and mouth disease (HFMD) (n=579). Natural exposure to EV71 and CA16 was evaluated on Seroprevalence of neutralizing antibodies to EV71 and CA16 subgenotypes. Seropositivity against EV71 and CA16 was lowest in children aged 6-11 months and gradually increased with age, remaining below 50% in children younger than 3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: